|
Press Releases |
|
|
|
Tuesday, October 24, 2017 |
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
Tuesday, August 15, 2017 |
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
Thursday, June 15, 2017 |
|
First-Year Performance of Global Systematic Multi-Strategy Fund |
The Board of Directors of Singapore eDevelopment Ltd ("SeD") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation. more info >> |
|
Monday, May 22, 2017 |
|
Singapore eDevelopment's Global BioLife Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Ltd ("SeD"), through its subsidiary Global BioLife Inc. ("Global BioLife"), has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee, Mr Daryl Thompson. more info >> |
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
《"株のアルゴリズム取引"を個人投資家も実現可能に!》 株の自動売買アプリ「Trade Stand(トレスタ)」が 大幅アップデートを発表
Apr 25, 2024 12:00: JST
|
|
|
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
|
|
|
Elevate Your Sleep Game This World Health Day with LAC
Apr 25, 2024 09:00 HKT/SGT
|
|
|
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 9:00 JST
|
|
|
GA-ASI Selected to Build CCA for AFLCMC
Apr 25, 2024 07:00 HKT/SGT
|
|
|
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences
Apr 25, 2024 01:47 HKT/SGT
|
|
|
The South China Sea: A Nuanced Understanding Required
Apr 24, 2024 21:12 HKT/SGT
|
|
|
Kontent.ai Introduces Mission Control and New Brand Identity, Leading a New Era of Content Management
Apr 24, 2024 20:51 HKT/SGT
|
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验
Apr 24, 2024 19:07 HKT/SGT
|
|
|
業聚醫療合資企業在中國內地啟動TricValve臨床試驗
Apr 24, 2024 19:04 HKT/SGT
|
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
Apr 24, 2024 18:59 HKT/SGT
|
|
|
Legacy Credit Emerges as a Substantial Shareholder in VCI Global
Apr 24, 2024 18:00 HKT/SGT
|
|
|
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST
|
|
|
MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST
|
|
|
三菱重工、タイの超大型複合火力発電所プロジェクトでM701JAC形GTCCの7系列目が運転開始
Apr 24, 2024 14:30: JST
|
|
|
|
More News >> |
|
|
|
|
|